Stay Informed
Identifying outcomes reported in trials of interventions in venous leg ulceration for a core outcome set development: a scoping review
2022
J Tissue Viability; 31: 751-760.
Read MoreMost healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis
2022
J Clin Epidemiol; 148: 160-9.
Read MoreOsteopathic manipulative treatment for pediatric conditions: an update of systematic review and meta-analysis
2022
J Clin Med; 11: 4455.
Read MoreFaecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)
2022
Gut; 71: 1939-1962.
Read MoreComparison of patients with head and neck cancer in randomized clinical trials and clinical practice: a systematic review
2022
JAMA Otolaryngol Head Neck Surg; 148: 670-676.
Read MoreQUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies
2022
Ann Intern Med; 175: 1010-1018.
Read MoreGuideline for the diagnosis and treatment of Faecal Incontinence-A UEG/ESCP/ESNM/ESPCG collaboration
2022
United European Gastroenterol J; 10: 251-86.
Read MoreA scattered landscape: assessment of the evidence base for 71 patient decision aids developed in a hospital setting
2022
BMC Med Inform Decis Mak; 22: 44.
Read MoreBelimumab for treating active autoantibody-positive systemic lupus erythematosus: an Evidence Review Group perspective of a NICE STA
2022
Pharmacoeconomics;40:851-861.
Read MoreLiving systematic reviews in rehabilitation science can improve evidence-based healthcare
2021
Syst Rev; 10: 309.
Read MoreTranscatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis
2021
BMJ Open; 11: e054222.
Read MoreQUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies
2021
Ann Intern Med; 174: 1592-9.
Read MoreMogamulizumab for previously treated mycosis fungoides and Sézary syndrome: an Evidence Review Group perspective of a NICE single technology appraisal
2021
Pharmacoeconomics; 40: 509-18.
Read MoreLongitudinal outcome evaluations of interdisciplinary multimodal pain treatment programs for patients with chronic primary musculoskeletal pain: a systematic review and meta-analysis
2021
Eur J Pain; 26: 310-35.
Read MoreFilgotinib for moderate to severe rheumatoid arthritis: an Evidence Review Group perspective of a NICE single technology appraisal
2021
Pharmacoeconomics; 39: 1397-1410.
Read MoreChallenges and controversies in the surgical treatment of cervical cancer: open radical hysterectomy versus minimally invasive radical hysterectomy
2021
J Clin Med; 10: 3761.
Read MoreModeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden
2021
J Med Econ; 24: 770-80.
Read MoreHigh-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation
2021
Health Technol Assess; 25: 1-276.
Read MoreSpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review
2021
Urology; 156: e74-e85.
Read MoreHeterogeneity in outcome selection, definition and measurement in studies assessing the treatment of cryptoglandular anal fistula: findings from a systematic review
2021
Tech Coloproctol; 25: 761-830.
Read MoreDevelopment of a core outcome set for venous leg ulceration (CoreVen) research evaluations (protocol)
2021
J Tissue Viability; 30: 317-23.
Read MoreDNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review
2021
Future Oncol; 17: 853-64.
Read MoreThe development of a faecal incontinence core outcome set: an international Delphi study protocol
2021
Int J Colorectal Dis; 36: 617-22.
Read More